# 24-months Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor

> **NCT06570421** · NA · RECRUITING · sponsor: **Stimvia s.r.o.** · enrollment: 20 (estimated)

## Conditions studied

- Parkinson Disease
- Essential Tremor

## Interventions

- **DEVICE:** Peroneal electrical transcutaneous neuromodulation (peroneal eTNM®)

## Key facts

- **NCT ID:** NCT06570421
- **Lead sponsor:** Stimvia s.r.o.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-19
- **Primary completion:** 2026-07
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06570421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06570421, "24-months Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06570421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*